`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`___________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`___________
`
`LASSEN THERAPEUTICS 1, INC.,
`Petitioner,
`v.
`
`SINGAPORE HEALTH SERVICES PTE LTD., AND
`NATIONAL UNIVERSITY OF SINGAPORE,
`Patent Owners.
`___________
`
`Case No. PGR2019-00053
`Patent 10,106,603 B2
`
`__________
`
`
`
`
`PATENT OWNERS’ FIRST UPDATED MANDATORY NOTICES
`
`7711773.1
`
`
`
`
`
`Patent Owners Singapore Health Services PTE LTD. and National
`
`University of Singapore hereby make the following updates to their Mandatory
`
`Notices.
`
`I.
`
`REAL PARTY-IN-INTEREST
`[No change.]
`
`Patent Owners Singapore Health Services PTE LTD. and National
`
`University of Singapore, and licensee Enleofen Bio Pte Ltd, are the Real Parties-
`
`in-Interest.
`
`II. RELATED MATTERS
`[No change.]
`
`A. United States Patent & Trademark Office
`The application from which U.S. Patent No. 10,106,603 issued is a Division
`
`of U.S. Patent Application No. 15/381,622 (U.S. Patent No. 10,035,852).
`
`The U.S. patent applications pending under the following serial numbers
`
`claim the benefit of the priority of the filing date of U.S. Patent No. 10,106,603:
`
`16/055,245; 16/055,251; 16/055,261; 16/055,270; 16/055,283; 16/055,295;
`
`16/055,304; 16/055,319; 16/106,041; 16/106,044; 16/106,047; 16/106,050.
`
`
`
`
`
`
`
`1
`
`
`
`Foreign Jurisdictions
`B.
`U.S. Patent No. 10,106,603 claims priority to United Kingdom Application
`
`No. 1522186.4. The following non-U.S. patent matters also claim priority to
`
`United Kingdom Application No. 1522186.4:
`
`Jurisdiction
`
`Application
`Number
`2016369407
`Australia
`2018229482
`Australia
`2018229483
`Australia
`2018229484
`Australia
`2018229485
`Australia
`2018229486
`Australia
`2018229487
`Australia
`3007750
`Canada
`201680074600.X
`China (People's Republic)
`European Patent Convention 16822941.7
`
`
`
`2
`
`Publication Number
`(Kind Code)
`2016369407 (B2)
`2018229482 (A1)
`2018229483 (A1)
`2018229484 (A1)
`2018229485 (A1)
`2018229486 (A1)
`2018229487 (A1)
`3007750 (A1)
`108495861 (A)
`3298040 (B1) (validated
`in Albania, Austria,
`Belgium, Bulgaria,
`Switzerland, Cyprus,
`Czech Republic,
`Germany, Denmark,
`Estonia, Spain, Finland,
`France, United
`Kingdom, Greece,
`Croatia, Hungary,
`Ireland, Iceland, Italy,
`Lithuania, Luxemburg,
`Latvia, Monaco, North
`Macedonia, Malta,
`Netherlands, Norway,
`Poland, Portugal,
`Romania, Serbia,
`Sweden, Slovenia,
`Slovakia, San Marino,
`and Turkey)
`
`
`
`3428186 (A1)
`European Patent Convention 18176010.9
`3428187 (A1)
`European Patent Convention 18185321.9
`3428188 (A1)
`European Patent Convention 18185326.8
`3431498 (A1)
`European Patent Convention 18185323.5
`3431499 (A1)
`European Patent Convention 18188947.8
`3431500 (A1)
`European Patent Convention 18188951.0
`1254287 (A)
`Hong Kong
`18113247.4
`2019-502689 (A)
`Japan
`2018-531325
`20180097645 (A)
`Republic of Korea
`10-2018-7020275
`744307 (A)
`New Zealand
`744307
`11201804836R (A)
`Singapore
`11201804836R
`201803727 (B)
`South Africa
`2018/03727
`Patent Cooperation Treaty
`PCT/EP2016/081430 WO 2017/103108 (A1)
`
`An Opposition to European Patent 3298040 (B1) was filed by Bayer
`
`Aktiengesellschaft on April 29, 2019.
`
`III. LEAD AND BACKUP COUNSEL
`Lead Counsel:
`
`Edward R. Gates, Registration No. 31,616
`
`Backup Counsel:
`
`Backup Counsel:
`
`
`
`
`
`Elisabeth H. Hunt, Registration No. 67,336
`
`Richard F. Giunta, Registration No. 36,149
`
`IV. SERVICE INFORMATION
`Patent Owners consent to electronic service of all documents to the below
`
`email addresses:
`
`Email:
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`EGates-PTAB@wolfgreenfield.com
`EHunt-PTAB@wolfgreenfield.com
`RGiunta-PTAB@wolfgreenfield.com
`
`3
`
`
`
`Postal Mail, Courier, or Hand Delivery:
`WOLF GREENFIELD & SACKS, P.C.
`600 Atlantic Avenue
`Boston, MA 02210
`Tel: (617) 646-8000
`Fax: (617) 646-8646
`
`
`
`
`
`
`
`
`
`
`
`POWER OF ATTORNEY
`The above-designated counsel are already counsel of record in the subject
`
`
`
`
`
`V.
`
`patent under PTO Customer Number 23628, and powers of attorney are of record
`
`in the patent’s file wrapper. Pursuant to 37 C.F.R. § 42.10(b), no additional power
`
`of attorney is being filed.
`
`
`
`Dated: 11/14/2019
`
`
`
`
`
`Respectfully submitted,
`Singapore Health Services PTE LTD.
`and National University of Singapore
`
`By /Edward R. Gates/
`Edward R. Gates, Reg. No. 31,616
`Elisabeth H. Hunt, Reg. No. 67,336
`Richard F. Giunta, Reg. No. 36,149
`WOLF GREENFIELD & SACKS, P.C.
`600 Atlantic Ave.
`Boston, MA 02210-2206
`Tel: 617-646-8000/Fax: 617-646-8646
`
`
`
`4
`
`
`
`CERTIFICATE OF SERVICE UNDER 37 C.F.R. § 42.6 (e)(4)
`
`I certify that on November 14, 2019, I will cause a copy of the foregoing
`
`document, including any exhibits referred to therein, to be served via electronic
`
`mail, as previously consented to by Petitioner, upon the following:
`
`Christopher P. Bruenjes
`Mercedes K. Meyer
`
`William S. Foster, Jr.
`
`
`christopher.bruenjes@dbr.com
`mercedes.meyer@dbr.com
`
`william.foster@dbr.com
`
`
`
`
`
`
`
`
`Dated: November 14, 2019
`
`
`
`
`
`
`
`/MacAulay Rush /
`MacAulay Rush
`Patent Paralegal
`WOLF GREENFIELD & SACKS, P.C.
`
`
`
`5
`
`